China News
-
WuXi inks cancer biomarker service deal with US firm
China | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: US based Targos, clinical biomarker service provider has signed a collaboration deal with China's WuXi Pharma...Read more
-
Big Pharma continues acquisitions
China | Analysis | By BioSpectrum Bureau | 0 Comment | 19 Jun, 2012
The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month...Read more
-
AZ, WuXi enter first-of-its-kind biotech deal in China
China | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2012
Singapore: AstraZeneca has established a joint venture (JV) with WuXi AppTec, China, to develop a new biotech medicine. ...Read more
-
BGI-Shenzhen extends tender offer for Complete
China | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013
Singapore: BGI-Shenzhen (BGI) announced that its wholly-owned subsidiary Beta Acquisition, has extended its all cash te...Read more
-
What functional roles do CROs play in APAC?
China | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
China flu outbreak spooks Tibet, Sri Lanka
China | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: The Tibetan Ministry of Agriculture revealed on Tuesday, May 14, 2013, that a fresh outbreak of the older str...Read more
-
Bayer confirms probe by Chinese antitrust officials
China | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Issuing a statement to the media confirming a probe at its Chinese offices, German drug giant Bayer has now s...Read more
-
Huahai, Oncobiologics enter generics partnership
China | News | By BioSpectrum Bureau | 0 Comment | 10 May, 2013
Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for t...Read more
-
BMS gives $1.69 Mn hepatitis grant to India and China
China | News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2012
Singapore: The Bristol-Myers Squibb Foundation has awarded four new grants totaling $1.69 million to improve prevention,...Read more
-
Fosun Pharma buys laser medtech firm for $240 mn
China | News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2013
‎Singapore: Shanghai-based Fosun Pharmaceutical, along with Pramerica-Fosun Fund, is acquiring a 95.6 percent stak...Read more
-
Bulgaria-China spur bilateral cooperation
China | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
Singapore: Bulgaria and China held a trade and cooperation event on pharmaceuticals and medical devices, aimed at the de...Read more
-
China | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2015
Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...Read more
-
China National Biotec, Riboxx ink collaboration
China | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaborati...Read more
-
BSA-CMR Survey: New CRO players emerge in APAC
China | Analysis | By BioSpectrum Bureau | 4 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
-
Nose cancer emerges as a potent killer in Asia
China | Analysis | By BioSpectrum Bureau | 2 Comment | 19 Sep, 2013
Singapore: Nasopharyngeal carcinoma (NPC) is a rare form of cancer in Western Europe and North America and is emerging a...Read more
-
UN: Child deaths down by half since 1990
China | News | By BioSpectrum Bureau | 0 Comment | 16 Sep, 2013
Singapore: In 2012, approximately 6.6 million children worldwide, died at the rate of 18,000 per day before reaching the...Read more
-
Alchemia gets US patent for oncology platform technology
China | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...Read more
-
China National Accord's R&D strategy begins to pay-off
China | Analysis | By BioSpectrum Bureau | 0 Comment | 31 May, 2013
China National Accord Medicines Corporation utilized 2012 as a year to speed up the transformation and upgrade scienti...Read more
